Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chloracne and chloracnegens.

J P Tindall

    Journal of the American Academy of Dermatology
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Chloracne is a persistent skin condition caused by toxic halogenated aromatic compounds. Early recognition and long-term medical monitoring are crucial for affected individuals due to potential systemic effects and oncogenic risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aseptic (avascular) necrosis of the femoral head in psoriasis.

    Southern medical journal·1979
    Same author

    Skin changes and lesions in our senior citizens: incidences.

    Cutis·1976
    Same author

    Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.

    JAMA·1975
    Same author

    Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytoses.

    The Journal of investigative dermatology·1975
    Same author

    Relieving localized and generalized pruritus.

    Geriatrics·1975
    Same author

    Medical uses of intra-arterial injections of reserpine. Treatment of Raynaud syndrome and of some vascular insufficiencies of the lower extremities.

    Archives of dermatology·1974
    Same journal

    Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

    Journal of the American Academy of Dermatology·2026
    Same journal

    The Ethics of the Handshake in Dermatology.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Dermatology images: Hidradenitis suppurativa.

    Journal of the American Academy of Dermatology·2026
    See all related articles

    Area of Science:

    • Toxicology
    • Dermatology
    • Environmental Health

    Background:

    • Chloracne is a severe acne-like skin condition linked to exposure to halogenated aromatic compounds.
    • It represents a systemic poisoning, not merely a dermatological issue.
    • This condition has been a recognized health problem for over four decades.

    Purpose of the Study:

    • To highlight the significance of chloracne as a symptom of systemic poisoning.
    • To emphasize the need for medical practitioners, especially dermatologists, to be familiar with chloracne.
    • To underscore the challenges in treating chloracne and its long-term implications.

    Main Methods:

    • This abstract is based on a review of existing knowledge and clinical observations regarding chloracne.
    • The text synthesizes information on the causes, symptoms, and management of chloracne.

    Related Experiment Videos

  • It draws upon clinical experience and toxicological data related to halogenated aromatic compounds.

    • Main Results:

    • Chloracne is difficult to treat and can persist long after exposure to the causative agents (chloracnegens).
    • Some chloracnegens can induce various systemic effects and may possess carcinogenic potential.
    • Fewer than 4,000 individuals worldwide are estimated to have chloracne.

    Conclusions:

    • Individuals diagnosed with chloracne require regular medical evaluation and lifelong follow-up.
    • Early identification and understanding of chloracne are essential for effective patient management.
    • The systemic nature and potential long-term health risks necessitate a comprehensive medical approach.